Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer

NCT02467569 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms，Non-Small Cell Lung Cancer

Interventions

DRUG: Hemay020

Sponsor

Tianjin Hemay Pharmaceutical Co., Ltd

Collaborators

[object Object]